Florida Oncology & Hematology

What Florida Oncology & Hematology does

Florida Oncology & Hematology is a community-based medical oncology and hematology practice operating five outpatient clinic locations across Southwest Florida — Cape Coral, Clearwater, Fort Myers, and two sites in Naples (Goodlette and Lintree). The practice treats patients diagnosed with all major solid tumor types (breast, lung, colorectal, prostate, pancreatic, and others) and hematologic malignancies (lymphoma, leukemia, multiple myeloma, MDS, aplastic anemia), as well as benign blood disorders and autoimmune abnormalities. Care is delivered by 9 board-certified medical oncologists and hematologists supported by 15 advanced practice providers (nurse practitioners and physician assistants), with clinical staff distributed across the five sites.

The service model is a vertically integrated, one-roof community oncology platform. Core clinical services include medical oncology (chemotherapy, immunotherapy, targeted therapy, oral chemotherapy), hematology, and emerging modalities such as BiTE (bispecific T-cell engager) therapy and radioligand therapy. Diagnostic and treatment-support infrastructure comprises on-site CT and PET/CT imaging, a centralized pathology laboratory, and an in-house specialty pharmacy dispensing oral oncolytics with 24/7 pharmacist access and FedEx delivery. Surrounding services include oncology clinician-led care coordination and navigation, clinical trial enrollment, financial counseling and patient-assistance navigation, a survivorship program, and (newly added through AON partnerships) CanCare peer emotional support and Colla Health behavioral health services. The practice participates in Medicare's Principal Care Management and Enhancing Oncology Model programs, aligning with value-based care reimbursement structures.

Commercially, the practice operates as a for-profit private entity and is a partner practice of American Oncology Network (AON), founded in 2018, which represents more than 350 oncology providers across 21 states. Revenue is generated through fee-for-service insurance reimbursement (Medicare, Medicaid, commercial payers) and patient payments; pricing is not publicly disclosed. Patients access the practice via physician referrals, self-referrals, or second opinions. Florida Oncology & Hematology has executed multiple recent expansions: three clinic relocations to larger facilities in 2025 (Fort Myers, Naples-Goodlette, Naples-Lintree), addition of PET services at two sites, and the launch of BiTE therapy and radioligand therapy. Two new physicians joined the team in 2025 and 2026, and AON-level partnerships with CanCare and Colla Health were announced in June 2026.

Name

Florida Oncology & Hematology

Legal name

Florida Oncology & Hematology

Website

https://floridaonc.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Florida Oncology & Hematology is a community-based medical oncology and hematology practice delivering comprehensive cancer and blood-disorder care across five Florida clinic locations, supported by 9 physicians and 15 advanced practice providers as a partner of American Oncology Network.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Healthcare Services

NAICS

Offices of Physicians (62111), Medical and Diagnostic Laboratories (62151)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industry

Hematologic Oncology (Leukemia/Lymphoma/Myeloma) (HLAKAFAD)

Keywords

• Medical oncology services
• Hematology treatment
• Infusion therapy
• Cancer diagnostics
• Specialty pharmacy services

Headquarters

HQ city

Cape Coral

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Patient Care Services: Billable medical oncology and hematology services including chemotherapy, immunotherapy, targeted therapy, oral chemotherapy, infusion therapy, diagnostic imaging, pathology, pharmacy, and clinical trial treatments. Revenue generated through insurance reimbursement (Medicare, Medicaid, commercial payers) and patient payments.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Florida Oncology & Hematology is a community-based medical oncology and hematology practice providing cancer and blood disorder care including chemotherapy, immunotherapy, targeted therapies, oral chemotherapy, BiTE therapy, and radioligand therapy. The practice supports treatment with on-site diagnostic imaging (CT/PET-CT), centralized pathology, an in-house specialty pharmacy, care coordination, clinical trials, financial counseling, and behavioral health partnerships across five Florida clinic locations.

Product overview

Florida Oncology & Hematology is a community-based medical oncology and hematology practice providing comprehensive cancer care through integrated services. The practice operates a multi-service model combining Medical Oncology and Hematology as core treatment services with specialized therapies including BiTE Therapy (bispecific antibody therapy) and Radioligand Therapy for targeted cancer treatment. Diagnostic capabilities include on-site Diagnostic Imaging (CT and PET/CT scans) and Pathology laboratory services. Support services include an in-house Pharmacy for oral cancer medications, Care Coordination & Navigation, Clinical Trials access, and Financial Support counseling. The practice also provides holistic patient support through CanCare peer support and Colla Health behavioral health services partnerships. Services are delivered through a team of 9 board-certified physicians and 15 advanced practitioners across 5 Florida locations in Cape Coral, Clearwater, Fort Myers, and Naples.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology

Quantifiable outcome

• Community oncology patients with stage IV metastatic breast cancer experienced median survival of 48 months vs. 40 months in SEER benchmark; for metastatic NSCLC, 15 months vs. 13 months benchmark

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• Colla HealthcoreStrategic or Co-development Partner · 30 June 2026Partnership provides personalized emotional support, targeted therapeutic interventions, and psychiatric oversight and consultation for cancer patients. Colla Health's oncology-focused behavioral health specialists provide evidence-based emotional and behavioral support via telehealth and phone sessions, coordinated alongside the oncology team. Services include support for anxiety, stress, depression, grief, fear of recurrence, sleep challenges, and cognitive changes. Insurance-covered services available for eligible patients. The program is available to all AON partner practices nationwide.
• CanCare, Inc.coreStrategic or Co-development Partner · 10 June 2026Partnership connects cancer patients and their families with trained volunteer survivors and caregivers who provide one-to-one emotional support based on shared experiences. Support is free and available by phone, email, text, or in person. CanCare volunteers complete a comprehensive training program and are carefully matched with patients. The service is available at every stage of the cancer journey. A pilot program at four AON practices including Florida Oncology & Hematology demonstrated positive patient feedback before the broader national rollout.
• American Oncology Network (AON)coreStrategic or Co-development PartnerFlorida Oncology & Hematology is a partner practice of American Oncology Network, one of the nation's fastest-growing community oncology networks. AON was founded in 2018 and represents 350+ providers practicing across 21 states. AON provides comprehensive support including integrated revenue-diversifying ancillary services, practice management expertise, value-based care programs, and access to clinical trials. AON's network enables the practice to offer radiotheranostic services, RLT capabilities, and participate in the Medicare Principal Care Management and Enhancing Oncology Model.

Scale indicators5 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• Florida Cancer Specialists & Research Institute: Largest community oncology practice in Florida with deep penetration across the same Southwest Florida geography as FOH. Several FOH physicians previously worked there, and it competes directly for the same patients, referral sources, and clinical talent in Cape Coral, Fort Myers, and Naples.
• Texas Oncology: Large multi-site community oncology practice providing chemotherapy, infusion, imaging, and clinical trials across Texas. Operates a similar integrated service model with in-house pharmacy, pathology, and care coordination under a community-based delivery approach.
• The Oncology Institute of Hope and Innovation: Public community oncology platform offering medical oncology, hematology, infusion, and clinical trials across multiple states. Operates a value-based care model with comparable payer mix and similar service breadth to FOH, including in-house dispensing.
• Tennessee Oncology: Multi-site community oncology practice in Tennessee offering comprehensive medical oncology, hematology, imaging, and clinical research services. Operates a similar integrated model including in-house specialty pharmacy and centralized lab/pathology.
• Carolina Blood and Cancer Care Associates: Multi-physician community hematology and oncology practice in the Carolinas providing chemotherapy, infusion, clinical trials, and in-house lab services. Comparable in scale to FOH and operates an analogous integrated delivery model.

Broad incumbents

• US Oncology Network (McKesson): One of the largest U.S. community oncology networks, owned by McKesson, with extensive geographic coverage and broad service offerings including pharmacy, diagnostics, and value-based care programs. Represents a structurally similar but much larger community oncology model.
• OneOncology: National partnership of independent community oncology practices offering practice management, value-based care, and clinical research infrastructure. Operates as a competitor alliance to AON and partners with practices in overlapping geographies.

Others

• American Oncology Network (AON): Parent organization and alliance partner of FOH, operating 350+ providers across 21 states. Not a direct competitor but the closest operational analog and the entity that FOH's structure, service offering, and growth trajectory are benchmarked against.

Emerging players

• Moffitt Cancer Center: National Cancer Institute-designated comprehensive cancer center based in Tampa, FL, with outreach across the state. Competes for complex cases, clinical trial patients, and physician talent in the same Florida geographies served by FOH.
• Sylvester Comprehensive Cancer Center (UHealth): Academic NCI-designated cancer center in South Florida. Competes for high-acuity cases in the same Naples/Fort Myers geographies as FOH, particularly for advanced therapies and clinical trials that FOH now offers through AON.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/FloridaOnc

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Florida Oncology & Hematology